Bacteria, polysaccharides, vaccines and boosting: Measuring and maintaining population immunity

Archives of Disease in Childhood

Volumn 93, Issue 8, 2008, Pages 646-647

  Goldblatt, David ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; POLYSACCHARIDE; VACCINE;

BACTERIAL IMMUNITY; BACTERIAL INFECTION; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION; ADOLESCENT; BACTERIAL MEMBRANE; CHILD; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNOLOGY; INFANT; NOTE; PRESCHOOL CHILD;

ADOLESCENT; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CHILD; CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; POLYSACCHARIDES; VACCINES, CONJUGATE;

EID: 49049089176     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.133124     Document Type: Short Survey

References (7)

1. Avery OT, Goebel WF. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-proteins. J Exp Med 1929;50:521-33.
2. Booy R, Heath PT, Slack MPE, et al. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997;349(9060):1197-202.
3. Ramsay ME, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003;188(4):481-5.
4. Ladhani S, Slack MP, Heys M, et al. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008;93:665-9.
5. McVernon J, Andrews N, Slack MPE, et al. Host and environmental factors associated with Hib in England, 1998-2002. Arch Dis Child 2008;93:670-5.
6. Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364(9431):365-7.
7. Goldblatt D, Southern J, Ashton L, et al. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 2006;25(4):312-19.